全球藥物研發服務市場（2023-2030）：按類型（小分子、聚合物）和最終用戶（製藥和生物技術公司、學術機構）分類的規模、佔有率、成長分析和預測

根據預測，全球藥物研發服務市場規模將從2021年的32.6億美元和2022年的35億美元成長到2030年的66億美元，預測期內年複合成長率為7.3%。

全球藥物研發服務市場的促進因素

對各種治療目的的新療法的需求不斷增加

• 對慢性病新療法的需求不斷成長以及全球醫療保健行業的進步預計將成為市場擴張的主要驅動力。隨著製藥和生物製藥公司將研發活動委託給CRO，CRO提供研發服務並創建參與模型以最大限度地提高研發效率。此外，慢性病負擔的增加迫使政府和製藥公司尋求解決方案並增加對臨床試驗的投資。由於這些原因，對藥物研發服務的需求預計將會擴大。

全球藥物研發服務市場趨勢

• 市場正在見證幾個正在塑造其前景的關鍵市場趨勢。首先，隨著製藥和生技公司尋求專業服務提供者來進行藥物研發活動，外包顯著增加。透過這樣做，公司可以專注於自己的核心競爭力，同時利用專業知識、尖端技術和具有成本效益的解決方案。另一個重要趨勢是製藥公司和 CRO 之間轉向合作關係。這種夥伴關係能夠共用資源、專業知識和風險，促進創新並加速藥物研發過程。技術進步在藥物研發服務市場中發揮重要作用。高通量篩選、人工智慧和基因組學等技術正在徹底改變藥物研發過程，以便更快、更有效地識別和最佳化候選藥物研發。

本報告調查了全球藥物研發服務市場，並提供了市場概況、影響市場的各種因素分析、技術和創新趨勢、法律制度、市場規模趨勢和預測，以及按各個細分市場和地區進行的細分。總結了主要企業的細分、競爭形勢和概況。

目錄

• 執行摘要
• 調查方法
• 母市場分析
  • 市場概況
  • 市場規模
  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
• 關鍵市場洞察
  • 技術分析
  • 價格分析
  • 供應鏈分析
  • 價值鏈分析
  • 市場生態系統
  • 智慧財產權分析
  • 貿易分析
  • 啟動分析
  • 原料分析
  • 創新矩陣
  • 研發線產品分析
  • 總體經濟指標
  • 重點投資分析
  • 關鍵成功因素
  • 競爭程度
  • 市場動態及展望
    • 市場動態
      • 促進因素
      • 機會
      • 抑制因素
      • 任務
  • 法規狀況
  • 波特的分析
  • Skyquest 對未來顛覆的獨家見解
• 全球藥物研發服務市場：按類型
  • 市場概況
  • 低分子
  • 高分子
• 全球藥物研發服務市場：按最終用戶分類
  • 市場概況
  • 製藥和生物技術公司
  • 學術機構
• 全球藥物研發服務市場：按地區
  • 市場概況
  • 北美洲
  • 歐洲
  • 亞太地區
  • 拉丁美洲
  • 中東/非洲
• 競爭形勢
  • 前5名企業對比
  • 主要企業市場地位
  • 主要企業的招募策略
  • 關鍵成功策略
  • 近期市集活動
  • 主要企業市場佔有率
• 主要企業簡介
  • General Electric
  • Eurofins Scientific
  • PPD Inc.
  • Syngene International Limited
  • Wuxi AppTec
  • Frontage Labs
  • Galapagos NV
  • Aurigene Discovery Technologies
  • Genscript
  • Domainex
  • WIL Research Laboratories LLC
  • Shanghai Medicilon, Inc.
  • Labcorp Drug Development
  • Jubilant Biosys Ltd.
  • Evotec
  • Shanghai ChemPartner
  • Charles River Laboratories
  • Merck & Co. Inc.
  • Thermo Fisher Scientific Inc.
  • TCG Lifesciences Pvt Ltd.

Global Drug Discovery Services Market size was valued at USD 3.26 billion in 2021 and is poised to grow from USD 3.5 billion in 2022 to USD 6.6 billion by 2030, growing at a CAGR of 7.3% during the forecast period (2023-2030).

The Global Drug Discovery Services Market is a dynamic and rapidly evolving sector within the pharmaceutical and biotechnology industries. It encompasses a wide range of services and solutions aimed at discovering and developing new drugs to address various diseases and medical conditions. Drug discovery is a complex and resource-intensive process that involves the identification and validation of potential drug targets, the development of drug candidates, and rigorous testing for safety and efficacy. This process typically takes several years and requires significant investment in research and development (R&D). To streamline and expedite this process, pharmaceutical and biotechnology companies often seek the assistance of specialized drug discovery service providers. These service providers offer a diverse range of services to support the drug discovery process. They utilize advanced technologies, expertise, and infrastructure to accelerate the identification and optimization of potential drug candidates. These services may include target identification and validation, hit identification and lead optimization, medicinal chemistry, in vitro and in vivo testing, preclinical development, and early-phase clinical trials. In conclusion, the Global market plays a vital role in the drug development process, providing essential support and expertise to pharmaceutical and biotechnology companies. With the increasing demand for innovative therapies and the need for accelerated drug development, this market is expected to experience substantial growth in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Discovery Services Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Discovery Services Market Segmental Analysis

Global Drug Discovery Services Market is segmented by type, end-user, and region. Based on type, the market can be segmented into small molecules and large molecules. Based on end-user, the market is segmented into pharmaceutical & biotechnology companies and academic institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.

Drivers of the Global Drug Discovery Services Market

Rising demand for novel therapies for various therapeutic purposes

• Drug-finding services rising demand for novel treatments for chronic diseases and advancements in the global healthcare industry are predicted to be the main drivers of market expansion. Pharmaceutical and biopharmaceutical businesses still contract out their research and development (R&D) activities to CROs, which offer R&D services and create engagement models to maximise R&D efficiency. Governments and pharmaceutical corporations are being forced to look for solutions and boost their investment in clinical trials as a result of the increased burden of chronic diseases. As a result, there will be a greater need for drug discovery services.

Restraints in the Global Drug Discovery Services Market

High cost of drug molecules and lack of skilled labour

• The two biggest challenges facing the market will be a scarcity of trained labour and a high failure rate for target medication molecules. Millions of dollars are spent on preclinical research to find a molecule or create a medicine, which drives up the price of drug development.

Market Trends of the Global Drug Discovery Services Key

• Global Drug Discovery Services Market is experiencing several key market trends that are shaping its landscape. Firstly, there is a noticeable increase in outsourcing as pharmaceutical and biotech companies seek specialized service providers to handle their drug discovery activities. By doing so, companies can access expertise, advanced technologies, and cost-effective solutions while focusing on their core competencies. Another significant trend is the shift towards collaborative partnerships between pharmaceutical companies and contract research organizations (CROs). These partnerships allow for shared resources, expertise, and risk-sharing, fostering innovation and accelerating the drug discovery process. Technological advancements play a vital role in the drug discovery services market. Technologies such as high-throughput screening, artificial intelligence, and genomics are revolutionizing the process, enabling faster and more efficient identification and optimization of drug candidates.

Table of Contents

• Executive Summary
  • Market Overview
  • Wheel of Fortune
• Research Methodology
  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations
• Parent Market Analysis
  • Market Overview
  • Market Size
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
• Key Market Insights
  • Technology Analysis
  • Pricing Analysis
  • Supply Chain Analysis
  • Value Chain Analysis
  • Ecosystem of the Market
  • IP Analysis
  • Trade Analysis
  • Startup Analysis
  • Raw Material Analysis
  • Innovation Matrix
  • Pipeline Product Analysis
  • Macroeconomic Indicators
  • Top Investment Analysis
  • Key Success Factor
  • Degree of Competition
• Market Dynamics & Outlook
  • Market Dynamics
• Drivers
• Opportunities
• Restraints
• Challenges
  • Regulatory Landscape
  • Porters Analysis
• Competitive rivalry
• Threat of Substitute Products
• Bargaining Power of Buyers
• Threat of New Entrants
• Bargaining Power of Suppliers
  • Skyquest Special Insights on Future Disruptions
• Political Impact
• Economic Impact
• Social Impact
• Technical Impact
• Environmental Impact
• Legal Impact
• Global Drug Discovery Services Market by Type
  • Market Overview
  • Small molecules and Large molecules
• Global Drug Discovery Services Market by End-User
  • Market Overview
  • Pharmaceutical & Biotechnology companies and Academic Institutes
• Global Drug Discovery Services Market Size by Region
  • Market Overview
  • North America
• USA
• Canada
  • Europe
• Germany
• Spain
• France
• UK
• Rest of Europe
  • Asia Pacific
• China
• India
• Japan
• South Korea
• Rest of Asia-Pacific
  • Latin America
• Brazil
• Rest of Latin America
  • Middle East & Africa (MEA)
• GCC Countries
• South Africa
• Rest of MEA
• Competitive Landscape
  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2021
  • Strategies Adopted by Key Market Players
  • Top Winning Strategies
• By Development
• By Company
• By Year
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2021
• Key Company Profiles
  • General Electric (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Eurofins Scientific (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • PPD Inc. (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Syngene International Limited (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Wuxi AppTec (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Frontage Labs (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Galapagos NV (Belgium)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Aurigene Discovery Technologies (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Genscript (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Domainex (U.K.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • WIL Research Laboratories LLC (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Shanghai Medicilon, Inc. (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Labcorp Drug Development (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Jubilant Biosys Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Evotec (Germany)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Shanghai ChemPartner (China)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Charles River Laboratories (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Merck & Co. Inc. (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • Thermo Fisher Scientific Inc. (U.S.)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments
  • TCG Lifesciences Pvt Ltd. (India)
• Company Overview
• Business Segment Overview
• Financial Updates
• Key Developments